The biological treatment of renal-cell carcinoma and melanoma

被引:45
作者
Nathan, PD [1 ]
Eisen, TG [1 ]
机构
[1] Royal Marsden Hosp, London SW3 6JJ, England
关键词
D O I
10.1016/S1470-2045(02)00650-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biological therapies are claiming a place in the routine management of some solid tumours. In this review we focus on the biological treatment of melanoma and renal-cell carcinoma, identifying the background to current practice and areas of promise that may be in routine clinical use in the near future. Melanomas and renal-cell carcinomas are particularly resistant to chemotherapy and radiotherapy and are characterised by the host immune response to the tumours. For this reason there has been particular interest in the biological therapy of these diseases. Biological therapies differ from chemotherapeutic approaches in their mechanism of action, time to response, and side-effect profiles. Although biological treatment has a long history, it is only with recent advances in immunology and molecular biology that progress has been made. In the next few years investigators expect to build on their research experience with biotherapeutic agents to provide tangible benefits for patients.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 92 条
[11]  
Basting R, 1999, ANTICANCER RES, V19, P1493
[12]  
BLANKE CD, 2001, P AN M AM SOC CLIN, V20, P1
[13]  
BLOOM HJG, 1973, CANCER, V32, P1066, DOI 10.1002/1097-0142(197311)32:5<1066::AID-CNCR2820320507>3.0.CO
[14]  
2-F
[15]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268
[16]  
BUKOWSKI R, 1999, P AM SOC CLIN ONCOL, V18, P1719
[17]  
BYSTRYN I, 1999, P AM SOC CLIN ONCOL, V18, P1673
[18]  
Chan AD, 1998, SEMIN ONCOL, V25, P611
[19]   Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J].
Childs, R ;
Chernoff, A ;
Contentin, N ;
Bahceci, E ;
Schrump, D ;
Leitman, S ;
Read, EJ ;
Tisdale, J ;
Dunbar, C ;
Linehan, WM ;
Young, NS ;
Barrett, AJ ;
Clave, E ;
Epperson, D ;
Mayo, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) :750-758
[20]   EFFECT OF THALIDOMIDE ON TUMOR-NECROSIS-FACTOR PRODUCTION AND ANTITUMOR-ACTIVITY INDUCED BY 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID [J].
CHING, LM ;
XU, ZF ;
GUMMER, BH ;
PALMER, BD ;
JOSEPH, WR ;
BAGULEY, BC .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :339-343